Impoyz

— THERAPEUTIC CATEGORIES —
  • Psoriasis

Impoyz Generic Name & Formulations

General Description

Clobetasol propionate 0.025%; crm.

Pharmacological Class

Corticosteroid.

How Supplied

Crm—60g

Generic Availability

NO

Impoyz Indications

Indications

Moderate to severe plaque psoriasis.

Impoyz Dosage and Administration

Adult

≥18yrs: apply thin layer twice daily; max 50g/week and 2 consecutive weeks' treatment per course. Discontinue when control is achieved. Wash hands after application. Do not occlude.

Children

<18yrs: not recommended.

Impoyz Contraindications

Not Applicable

Impoyz Boxed Warnings

Not Applicable

Impoyz Warnings/Precautions

Warnings/Precautions

Avoid use on face, scalp, axilla, groin, or other intertriginous areas. Do not use for diaper dermatitis or on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue if infection persists or worsens. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy. Nursing mothers.

Impoyz Pharmacokinetics

See Literature

Impoyz Interactions

Not Applicable

Impoyz Adverse Reactions

Adverse Reactions

Application site discoloration, burning, itching, irritation, dryness, folliculitis, acneiform eruptions, hypertrichosis, hypopigmentation, perioral dermatitis, allergic contact dermatitis (discontinue if irritation occurs), secondary infection, striae, miliaria; HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia, glucosuria.

Impoyz Clinical Trials

See Literature

Impoyz Note

Not Applicable

Impoyz Patient Counseling

See Literature